Pavel D. Dunaev
Kazan, TA 420012, Russian Federation
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Claudin-1 Contributes to Gastrointestinal Stromal Tumors (GIST) Resistance to Imatinib Mesylate (IM) via Regulation of FGFR-Signaling.
Journal: International journal of molecular sciences
Published: July 03, 2025
A novel terpene-BODIPY conjugates based fluorescent probes: Synthesis, spectral properties, stability, penetration efficiency into bacterial, fungal and mammalian cells.
Journal: Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy
Published: July 19, 2024
Imbalance between Actin Isoforms Contributes to Tumour Progression in Taxol-Resistant Triple-Negative Breast Cancer Cells.
Journal: International journal of molecular sciences
Published: March 26, 2024
Leaf Extract from European Olive (Olea europaea L.) Post-Transcriptionally Suppresses the Epithelial-Mesenchymal Transition and Sensitizes Gastric Cancer Cells to Chemotherapy.
Journal: Biochemistry. Biokhimiia
Published: March 11, 2024
Unraveling the Mechanisms of Sensitivity to Anti-FGF Therapies in Imatinib-Resistant Gastrointestinal Stromal Tumors (GIST) Lacking Secondary KIT Mutations.
Journal: Cancers
Published: October 11, 2023
Establishment and Characterization of Multi-Drug Resistant p53-Negative Osteosarcoma SaOS-2 Subline.
Establishment and Characterization of Multi-Drug Resistant p53-Negative Osteosarcoma SaOS-2 Subline.
Journal: Diagnostics (Basel, Switzerland)
Published: July 14, 2023
Infigratinib (BGJ 398), a Pan-FGFR Inhibitor, Targets P-Glycoprotein and Increases Chemotherapeutic-Induced Mortality of Multidrug-Resistant Tumor Cells.
Journal: Biomedicines
Published: February 10, 2022
The Design, Synthesis, and Biological Activities of Pyrrole-Based Carboxamides: The Novel Tubulin Inhibitors Targeting the Colchicine-Binding Site.
Journal: Molecules (Basel, Switzerland)
Published: August 03, 2021
2-APCAs, the Novel Microtubule Targeting Agents Active Against Distinct Cancer Cell Lines.
Journal: Molecules (Basel, Switzerland)
Published: December 22, 2020
Inhibition of AKT-Signaling Sensitizes Soft Tissue Sarcomas (STS) and Gastrointestinal Stromal Tumors (GIST) to Doxorubicin via Targeting of Homology-Mediated DNA Repair.
Journal: International journal of molecular sciences
Published: October 09, 2020
Last Updated: 09/26/2026